当前位置: X-MOL 学术N. Engl. J. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
The New England Journal of Medicine ( IF 158.5 ) Pub Date : 2022-12-22 , DOI: 10.1056/nejmoa2205982
Evan S Dellon 1 , Marc E Rothenberg 1 , Margaret H Collins 1 , Ikuo Hirano 1 , Mirna Chehade 1 , Albert J Bredenoord 1 , Alfredo J Lucendo 1 , Jonathan M Spergel 1 , Seema Aceves 1 , Xian Sun 1 , Matthew P Kosloski 1 , Mohamed A Kamal 1 , Jennifer D Hamilton 1 , Bethany Beazley 1 , Eilish McCann 1 , Kiran Patel 1 , Leda P Mannent 1 , Elizabeth Laws 1 , Bolanle Akinlade 1 , Nikhil Amin 1 , Wei Keat Lim 1 , Matthew F Wipperman 1 , Marcella Ruddy 1 , Naimish Patel 1 , David R Weinreich 1 , George D Yancopoulos 1 , Brad Shumel 1 , Jennifer Maloney 1 , Angeliki Giannelou 1 , Arsalan Shabbir 1
Affiliation  

New England Journal of Medicine, Volume 387, Issue 25, Page 2317-2330, December 2022.


中文翻译:

Dupilumab 用于患有嗜酸性粒细胞性食管炎的成人和青少年

新英格兰医学杂志,第 387 卷,第 25 期,第 2317-2330 页,2022 年 12 月。
更新日期:2022-12-22
down
wechat
bug